Bank of America’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $531K | Sell |
|
|||||
|
2025
Q2 | $706K | Buy |
|
|||||
|
2025
Q1 | $558K | Sell |
|
|||||
|
2024
Q4 | $615K | Buy |
|
|||||
|
2024
Q3 | $467K | Buy |
|
|||||
|
2024
Q2 | $437K | Sell |
|
|||||
|
2024
Q1 | $4.97M | Buy |
|
|||||
|
2023
Q4 | $115K | Sell |
|
|||||
|
2023
Q3 | $184K | Sell |
|
|||||
|
2023
Q2 | $2.23M | Sell |
|
|||||
|
2023
Q1 | $11.1M | Buy |
|
|||||
|
2022
Q4 | $2.11M | Sell |
|
|||||
|
2022
Q3 | $3.44M | Sell |
|
|||||
|
2022
Q2 | $5.22M | Buy |
|
|||||
|
2022
Q1 | $3.52M | Sell |
|
|||||
|
2021
Q4 | $6.09M | Buy |
|
|||||
|
2021
Q3 | $5.28M | Buy |
|
|||||
|
2021
Q2 | $5.98M | Buy |
|
|||||
|
2021
Q1 | $3.79M | Buy |
|
|||||
|
2020
Q4 | $2.88M | Sell |
|
|||||
|
2020
Q3 | $2.81M | Buy |
|
|||||
|
2020
Q2 | $2.79M | Buy |
|
|||||
|
2020
Q1 | $2.44M | Buy |
|
|||||
|
2019
Q4 | $3.15M | Sell |
|
|||||
|
2019
Q3 | $3M | Sell |
|
|||||
|
2019
Q2 | $6.62M | Sell |
|
|||||
|
2019
Q1 | $11.4M | Buy |
|
|||||
|
2018
Q4 | $8M | Sell |
|
|||||
|
2018
Q3 | $7.52M | Buy |
|
|||||
|
2018
Q2 | $3.62M | Buy |
|
|||||
|
2018
Q1 | $3.1M | Buy |
|
|||||
|
2017
Q4 | $2.57M | Sell |
|
|||||
|
2017
Q3 | $3.42M | Buy |
|
|||||
|
2017
Q2 | $1.93M | Buy |
|
|||||
|
2017
Q1 | $977K | Buy |
|
|||||
|
2016
Q4 | $963K | Buy |
|
|||||
|
2016
Q3 | $621K | Buy |
|
|||||
|
2016
Q2 | $407K | Buy |
|
|||||
|
2016
Q1 | $158K | Sell |
|
|||||
|
2015
Q4 | $293K | Buy |
|
|||||
|
2015
Q3 | $354K | Sell |
|
|||||
|
2015
Q2 | $752K | Buy |
|
|||||
|
2015
Q1 | $526K | Buy |
|
|||||
|
2014
Q4 | $124K | Sell |
|
|||||
|
2014
Q3 | $149K | Buy |
|
|||||
|
2014
Q2 | $229K | Buy |
|
|||||
|
2014
Q1 | $129K | Sell |
|
|||||
|
2013
Q4 | $1.48M | Sell |
|
|||||
|
2013
Q3 | $2.65M | Buy |
|
|||||
|
2013
Q2 | $1.94M | Buy |
|